Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.

Calzetta L, Matera MG, Rogliani P, Cazzola M.

Expert Rev Respir Med. 2018 Jul 4. doi: 10.1080/17476348.2018.1495562. [Epub ahead of print]

PMID:
29972340
2.

Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?

Cazzola M, Matera MG, Rogliani P, Calzetta L.

Expert Opin Investig Drugs. 2018 Jul 4:1-9. doi: 10.1080/13543784.2018.1492548. [Epub ahead of print]

PMID:
29972333
3.

Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells.

Matera MG, Calzetta L, Gritti G, Gallo L, Perfetto B, Donnarumma G, Cazzola M, Rogliani P, Donniacuo M, Rinaldi B.

Eur J Pharmacol. 2018 Aug 5;832:114-119. doi: 10.1016/j.ejphar.2018.05.023. Epub 2018 May 18.

PMID:
29782855
4.

Anxiety and asthma in inner-city black adolescents: What could be the underestimated, possible connection?

Liccardi G, Calzetta L, Milanese M, Salzillo A, Apicella G, Matera MG, Rogliani P.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1093-1094. doi: 10.1016/j.jaip.2018.01.029. No abstract available.

PMID:
29747978
5.

Psychological Stress, Lung Function and Exacerbation Risk in COPD: Is an Increase of Cholinergic Tone a Possible Link?

Liccardi G, Calzetta L, Milanese M, Salzillo A, Manzi F, Ferrari M, Rogliani P.

COPD. 2018 May 7:1-2. doi: 10.1080/15412555.2018.1459533. [Epub ahead of print]

PMID:
29733688
6.

Efficacy and safety profile of xanthines in COPD: a network meta-analysis.

Cazzola M, Calzetta L, Barnes PJ, Criner GJ, Martinez FJ, Papi A, Gabriella Matera M.

Eur Respir Rev. 2018 May 2;27(148). pii: 180010. doi: 10.1183/16000617.0010-2018. Print 2018 Jun 30. Review.

7.

The safety of dual bronchodilation on cardiovascular serious adverse events in COPD.

Rogliani P, Ora J, Matera MG, Cazzola M, Calzetta L.

Expert Opin Drug Saf. 2018 Jun;17(6):589-596. doi: 10.1080/14740338.2018.1472232. Epub 2018 May 14. Review.

PMID:
29716427
8.

Impact of doxofylline in COPD: A pair-wise meta-analysis.

Cazzola M, Calzetta L, Rogliani P, Page C, Matera MG.

Pulm Pharmacol Ther. 2018 Apr 26. pii: S1094-5539(18)30094-4. doi: 10.1016/j.pupt.2018.04.010. [Epub ahead of print]

9.

Geographical characteristics influencing the risk of poisoning in pet dogs: Results of a large population-based epidemiological study in Italy.

Calzetta L, Roncada P, Piras C, Soggiu A, Liccardi G, Mattei M, Pistocchini E.

Vet J. 2018 May;235:63-69. doi: 10.1016/j.tvjl.2018.04.003. Epub 2018 Apr 6.

PMID:
29704941
10.

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways.

Calzetta L, Matera MG, Facciolo F, Cazzola M, Rogliani P.

Respir Res. 2018 Apr 12;19(1):65. doi: 10.1186/s12931-018-0770-7.

11.

N-Acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation.

Calzetta L, Rogliani P, Facciolo F, Rinaldi B, Cazzola M, Matera MG.

Biomed Pharmacother. 2018 Jul;103:1-8. doi: 10.1016/j.biopha.2018.04.011. Epub 2018 Apr 24.

12.

Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy.

Calzetta L, Matera MG, Cazzola M.

Curr Opin Pharmacol. 2018 Jun;40:95-103. doi: 10.1016/j.coph.2018.03.011. Epub 2018 Apr 4. Review.

PMID:
29626716
13.

Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysis.

Rogliani P, Matera MG, Puxeddu E, Mantero M, Blasi F, Cazzola M, Calzetta L.

Pulm Pharmacol Ther. 2018 Jun;50:28-37. doi: 10.1016/j.pupt.2018.03.004. Epub 2018 Mar 30.

PMID:
29609004
14.

Is ICS-LAMA an alternative option to treat patients with COPD?

Rogliani P, Calzetta L, Cazzola M.

Lancet Respir Med. 2018 May;6(5):316-317. doi: 10.1016/S2213-2600(18)30139-5. Epub 2018 Apr 5. No abstract available.

PMID:
29605621
15.

Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways.

Calzetta L, Rogliani P, Pistocchini E, Mattei M, Cito G, Alfonsi P, Page C, Matera MG.

J Vet Pharmacol Ther. 2018 Aug;41(4):546-554. doi: 10.1111/jvp.12504. Epub 2018 Mar 26.

PMID:
29582435
16.

How does race/ethnicity influence pharmacological response to asthma therapies?

Cazzola M, Calzetta L, Matera MG, Hanania NA, Rogliani P.

Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):435-446. doi: 10.1080/17425255.2018.1449833. Epub 2018 Mar 12. Review.

PMID:
29528249
17.

Benralizumab for the treatment of asthma.

Matera MG, Rogliani P, Calzetta L, Canonica GW, Cazzola M.

Drugs Today (Barc). 2017 Dec;53(12):633-645. doi: 10.1358/dot.2017.53.12.2736670. Review.

PMID:
29517082
18.

A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD.

Matera MG, Calzetta L, Puxeddu E, Rogliani P, Cazzola M.

Expert Opin Drug Saf. 2018 May;17(5):509-517. doi: 10.1080/14740338.2018.1448786. Epub 2018 Mar 8.

PMID:
29505318
19.

Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD.

Shute JK, Puxeddu E, Calzetta L.

Curr Opin Pharmacol. 2018 Jun;40:39-45. doi: 10.1016/j.coph.2018.01.006. Epub 2018 Feb 20. Review.

PMID:
29455115
20.

Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how.

Calzetta L, Matera MG, Rogliani P, Cazzola M.

Expert Rev Respir Med. 2018 Apr;12(4):261-264. doi: 10.1080/17476348.2018.1442216. Epub 2018 Feb 19. No abstract available.

PMID:
29451042
21.

Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study.

Liccardi G, Calzetta L, Baldi G, Berra A, Billeri L, Caminati M, Capano P, Carpentieri E, Ciccarelli A, Crivellaro MA, Cutajar M, D'Amato M, Folletti I, Gani F, Gargano D, Giannattasio D, Giovannini M, Lombardi C, Schiavo ML, Madonna F, Maniscalco M, Meriggi A, Micucci C, Milanese M, Montera C, Paolocci G, Parente R, Pedicini A, Pio R, Puggioni F, Russo M, Salzillo A, Scavalli P, Scichilone N, Sposato B, Stanziola A, Steinhilber G, Vatrella A, Rogliani P, Passalacqua G; Italian Allergic Respiratory Diseases Task Force.

Clin Mol Allergy. 2018 Feb 2;16:3. doi: 10.1186/s12948-018-0081-z. eCollection 2018.

22.

Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue.

Calzetta L, Rogliani P, Pistocchini E, Mattei M, Cito G, Alfonsi P, Page C, Matera MG.

Pulm Pharmacol Ther. 2018 Apr;49:88-94. doi: 10.1016/j.pupt.2018.01.010. Epub 2018 Jan 31.

PMID:
29408044
23.

Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis.

Calzetta L, Rogliani P, Page C, Roncada P, Pistocchini E, Soggiu A, Piras C, Urbani A, Matera MG.

Equine Vet J. 2018 Feb 2. doi: 10.1111/evj.12815. [Epub ahead of print]

PMID:
29393535
24.

Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life?

Liccardi G, Calzetta L, Salzillo A, Apicella G, Piccolo A, Di Maro E, Rogliani P.

Eur Ann Allergy Clin Immunol. 2017 Nov 30. doi: 10.23822/EurAnnACI.1764-1489.41. [Epub ahead of print]

PMID:
29384112
25.

Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy?

Liccardi G, Calzetta L, Milanese M, Lombardi C, Savi E, Passalacqua G, Rogliani P.

Hum Vaccin Immunother. 2018 Jun 3;14(6):1438-1441. doi: 10.1080/21645515.2018.1434383. Epub 2018 Feb 23.

PMID:
29381449
26.

Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

Jacobson GA, Raidal S, Hostrup M, Calzetta L, Wood-Baker R, Farber MO, Page CP, Walters EH.

Drug Saf. 2018 May;41(5):441-449. doi: 10.1007/s40264-017-0631-1.

PMID:
29332144
27.

Effect of adding roflumilast or ciclesonide to glycopyrronium on lung volumes and exercise tolerance in patients with severe COPD: A pilot study.

Rogliani P, Ora J, Puxeddu E, Calzetta L, Cavalli F, Matera MG, Cazzola M.

Pulm Pharmacol Ther. 2018 Apr;49:20-26. doi: 10.1016/j.pupt.2017.12.010. Epub 2017 Dec 30.

PMID:
29294360
28.

Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.

Matera MG, Rogliani P, Calzetta L, Cazzola M.

Expert Opin Drug Metab Toxicol. 2018 Feb;14(2):239-245. doi: 10.1080/17425255.2018.1421170. Epub 2017 Dec 27. Review.

PMID:
29268638
29.

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis.

Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 5;12:3469-3485. doi: 10.2147/COPD.S146338. eCollection 2017.

30.

Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.

Cazzola M, Calzetta L, Page C, Rogliani P, Matera MG.

Pulm Pharmacol Ther. 2018 Feb;48:185-194. doi: 10.1016/j.pupt.2017.11.009. Epub 2017 Dec 9.

PMID:
29233650
31.

What Could the Role of Can f 5 Allergen Be in Dog-Sensitized Patients in "Real Life"?

Liccardi G, Calzetta L, Salzillo A, Apicella G, Di Maro E, Rogliani P.

J Investig Allergol Clin Immunol. 2017;27(6):397-398. doi: 10.18176/jiaci.0189. No abstract available.

32.

Anxiety and asthma in youth. Is a stress-induced increased cholinergic tone the possible link?

Liccardi G, Calzetta L, Salzillo A, Piccolo A, Apicella G, Rogliani P.

Pediatr Pulmonol. 2018 Feb;53(2):128-129. doi: 10.1002/ppul.23904. Epub 2017 Nov 29. No abstract available.

PMID:
29193828
33.

Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.

Contoli M, Corsico AG, Santus P, Di Marco F, Braido F, Rogliani P, Calzetta L, Scichilone N.

COPD. 2017 Dec;14(6):641-647. doi: 10.1080/15412555.2017.1385056. Epub 2017 Nov 8.

PMID:
29116901
34.

Pharmacogenetic and pharmacogenomic considerations of asthma treatment.

Matera MG, Rinaldi B, Calzetta L, Cazzola M.

Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1159-1167. doi: 10.1080/17425255.2017.1391215. Epub 2017 Oct 23. Review.

PMID:
28992739
35.

Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study.

Shute JK, Calzetta L, Cardaci V, di Toro S, Page CP, Cazzola M.

Pulm Pharmacol Ther. 2018 Feb;48:88-96. doi: 10.1016/j.pupt.2017.10.001. Epub 2017 Oct 3.

PMID:
28986203
36.

Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus.

Cazzola M, Rogliani P, Calzetta L, Lauro D, Page C, Matera MG.

Trends Pharmacol Sci. 2017 Oct;38(10):940-951. doi: 10.1016/j.tips.2017.07.003. Epub 2017 Aug 7. Review.

PMID:
28784329
37.

Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.

Cazzola M, Rogliani P, Calzetta L, Hanania NA, Matera MG.

COPD. 2017 Oct;14(5):552-563. doi: 10.1080/15412555.2017.1347918. Epub 2017 Jul 28. Review.

PMID:
28753070
38.

Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.

Calzetta L, Rogliani P, Mattei M, Alfonsi P, Cito G, Pistocchini E, Cazzola M, Matera MG.

COPD. 2017 Oct;14(5):526-532. doi: 10.1080/15412555.2017.1344627. Epub 2017 Jul 26.

PMID:
28745522
39.

Anaphylaxis and intimate behaviour.

Liccardi G, Caminati M, Senna G, Calzetta L, Rogliani P.

Curr Opin Allergy Clin Immunol. 2017 Oct;17(5):350-355. doi: 10.1097/ACI.0000000000000386. Review.

PMID:
28742538
40.

Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.

Matera MG, Calzetta L, Rinaldi B, Cazzola M.

Expert Opin Drug Metab Toxicol. 2017 Sep;13(9):1007-1013. doi: 10.1080/17425255.2017.1359253. Epub 2017 Jul 24. Review.

PMID:
28737051
41.

Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis.

Calzetta L, Ora J, Cavalli F, Rogliani P, O'Donnell DE, Cazzola M.

Respir Med. 2017 Aug;129:189-198. doi: 10.1016/j.rmed.2017.06.020. Epub 2017 Jun 29. Review.

PMID:
28732830
42.

Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi.

Calzetta L, Rogliani P, Facciolo F, Rendina E, Cazzola M, Matera MG.

Eur J Pharmacol. 2017 Oct 5;812:147-154. doi: 10.1016/j.ejphar.2017.07.026. Epub 2017 Jul 14.

PMID:
28716723
43.

Withdrawal of inhaled corticosteroids in COPD: A meta-analysis.

Calzetta L, Matera MG, Braido F, Contoli M, Corsico A, Di Marco F, Santus P, Scichilone N, Cazzola M, Rogliani P.

Pulm Pharmacol Ther. 2017 Aug;45:148-158. doi: 10.1016/j.pupt.2017.06.002. Epub 2017 Jun 9.

PMID:
28606478
44.

Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine.

Calzetta L, Puxeddu E, Rogliani P.

EBioMedicine. 2017 May;19:14-15. doi: 10.1016/j.ebiom.2017.04.035. Epub 2017 Apr 28.

45.

Can a better patients' phenotyping predict the efficacy of tiotropium in symptomatic asthma?

Liccardi G, Calzetta L, Salzillo A, Apicella G, Croce G, Rogliani P.

Allergy Asthma Proc. 2017 May 1;38(3):19-20. doi: 10.2500/aap.2017.38.4045. No abstract available.

PMID:
28441979
46.

Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?

Liccardi G, Calzetta L, Salzillo A, Piccolo A, Pane G, Rogliani P.

Expert Opin Pharmacother. 2017 Jun;18(8):833-835. doi: 10.1080/14656566.2017.1317980. Epub 2017 Apr 28. No abstract available.

PMID:
28399659
47.

Partial renal resection by LaparoNewPro: in vivo open and laparoscopic study in an animal model.

Rossi P, Montuori M, Bove P, De Majo A, Ricciardi E, Mattei M, Bernardini R, Calzetta L, Mauti P, Intini L, Quattrini V, Chiaramonte C, Mauriello A, Vespasiani G.

Minim Invasive Ther Allied Technol. 2017 Dec;26(6):315-321. doi: 10.1080/13645706.2017.1307854. Epub 2017 Apr 5.

PMID:
28378603
48.

Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.

Cazzola M, Calzetta L, Rinaldi B, Page C, Rosano G, Rogliani P, Matera MG.

Drugs. 2017 May;77(7):721-732. doi: 10.1007/s40265-017-0731-3. Review.

PMID:
28349353
49.

Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis.

Calzetta L, Roncada P, di Cave D, Bonizzi L, Urbani A, Pistocchini E, Rogliani P, Matera MG.

Equine Vet J. 2017 Nov;49(6):710-717. doi: 10.1111/evj.12680. Epub 2017 Apr 9.

PMID:
28295526
50.

Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience.

Liccardi G, Calzetta L, Salzillo A, Billeri L, Lucà G, Rogliani P.

Eur Ann Allergy Clin Immunol. 2017 Mar;49(2):92-96.

PMID:
28294591

Supplemental Content

Loading ...
Support Center